Which drug keeps moms and babies safer during C-Sections?

NCT ID NCT06248593

Recruiting now Disease control Sponsor: Hassan II University Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 26, 2026 · Updated 1 time

Summary

This study compares two drugs, norepinephrine and phenylephrine, given as continuous infusions to maintain blood pressure during planned C-sections under spinal anesthesia. 140 healthy pregnant women will receive one of the two drugs, and researchers will measure effects on the baby's umbilical cord blood and the mother's vital signs. The goal is to find which drug offers better safety and stability for both mother and child.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: norepinephrine and phenylephrine (drugs to raise blood pressure)
What this could lead to: If one drug proves safer or more effective, it could become the preferred choice for managing blood pressure during C-sections, improving outcomes for mothers and newborns.
What could go wrong: This is a small, single-center trial comparing two well-known drugs, so the results may not apply to all hospitals or patients. Neither drug is expected to be a breakthrough.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CESAREAN SECTION COMPLICATIONS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

hypotensive disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CESAREAN SECTION COMPLICATIONS HYPOTENSION

Contacts and locations

Locations

University hospital Hassan II
NOT_YET_RECRUITING

Fes, 30060, Morocco
University hospital Hassan II
RECRUITING

Fes, 30060, Morocco

More trials for these conditions

Other studies related to the condition(s) this trial covers.